Healthcare provider profile · identity verified

John A Gill, MD

Family Practice · AUBURN, NE · NPI 1831294099

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	231	54
Atorvastatin Calcium	Atorvastatin Calcium	221	51
Meloxicam	Meloxicam	215	45
Levothyroxine Sodium	Levothyroxine Sodium	203	36
Lisinopril	Lisinopril	189	42
Metoprolol Succinate	Metoprolol Succinate	188	44
Amlodipine Besylate	Amlodipine Besylate	176	40
Prednisone	Prednisone	136	102
Simvastatin	Simvastatin	126	23
Metformin Hcl	Metformin Hcl	112	26
Tamsulosin Hcl	Tamsulosin Hcl	104	23
Fluticasone Propionate	Fluticasone Propionate	94	38
Losartan Potassium	Losartan Potassium	89	23
Gabapentin	Gabapentin	88	18
Paroxetine Hcl	Paroxetine Hcl	87	15
Furosemide	Furosemide	83	25
Montelukast Sodium	Montelukast Sodium	82	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	11
Alprazolam	Alprazolam	71	24
Ropinirole Hcl	Ropinirole Hcl	70	13
Sertraline Hcl	Sertraline Hcl	69	14
Celecoxib	Celecoxib	68	14
Duloxetine Hcl	Duloxetine Hcl	66	14
Pantoprazole Sodium	Pantoprazole Sodium	65	17
Hydrochlorothiazide	Hydrochlorothiazide	63	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	16
Allopurinol	Allopurinol	59	15
Glipizide Er	Glipizide	59	suppressed
Potassium Chloride	Potassium Chloride	58	15
Rosuvastatin Calcium	Rosuvastatin Calcium	56	11
Clonazepam	Clonazepam	53	14
Warfarin Sodium	Warfarin Sodium	52	16
Zolpidem Tartrate	Zolpidem Tartrate	52	15
Donepezil Hcl	Donepezil Hcl	47	11
Carvedilol	Carvedilol	45	14
Buspirone Hcl	Buspirone Hcl	44	suppressed
Azithromycin	Azithromycin	43	41
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	34
Eliquis	Apixaban	40	suppressed
Topiramate	Topiramate	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	39	31
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Cefdinir	Cefdinir	38	37
Tramadol Hcl	Tramadol Hcl	38	17
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	32
Tizanidine Hcl	Tizanidine Hcl	37	21
Pregabalin	Pregabalin	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Lorazepam	Lorazepam	32	14
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Jardiance	Empagliflozin	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Alcohol Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Diazepam	Diazepam	23	suppressed
Sotalol	Sotalol Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Atenolol	Atenolol	21	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Fluconazole	Fluconazole	17	11
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Ketoconazole	Ketoconazole	15	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Baclofen	Baclofen	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Linzess	Linaclotide	14	suppressed
Methimazole	Methimazole	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Modafinil	Modafinil	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ozempic	Semaglutide	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error